| Broad neutralization of SARS-related viruses by human monoclonal antibodies AZ Wec, D Wrapp, AS Herbert, DP Maurer, D Haslwanter, M Sakharkar, ... Science 369 (6504), 731-736, 2020 | 542 | 2020 |
| A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition ME Dieterle, D Haslwanter, RH Bortz, AS Wirchnianski, G Lasso, ... Cell host & microbe 28 (3), 486-496. e6, 2020 | 201 | 2020 |
| Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine AZ Wec, D Haslwanter, YN Abdiche, L Shehata, N Pedreño-Lopez, ... Proceedings of the National Academy of Sciences 117 (12), 6675-6685, 2020 | 85 | 2020 |
| Characterization of the SARS-CoV-2 S protein: biophysical, biochemical, structural, and antigenic analysis NG Herrera, NC Morano, A Celikgil, GI Georgiev, RJ Malonis, JH Lee, ... ACS omega 6 (1), 85-102, 2020 | 84 | 2020 |
| A novel mechanism of antibody-mediated enhancement of flavivirus infection D Haslwanter, D Blaas, FX Heinz, K Stiasny PLoS pathogens 13 (9), e1006643, 2017 | 71 | 2017 |
| Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC H ah Yoon, R Bartash, I Gendlina, J Rivera, A Nakouzi, RH Bortz III, ... JCI insight 6 (4), 2021 | 49 | 2021 |
| A combination of receptor-binding domain and N-terminal domain neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutants D Haslwanter, ME Dieterle, AZ Wec, CM O’brien, M Sakharkar, C Florez, ... Mbio 12 (5), 10.1128/mbio. 02473-21, 2021 | 36 | 2021 |
| Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines NA Muena, T García-Salum, C Pardo-Roa, EF Serrano, J Levican, ... MedRxiv, 2021 | 35 | 2021 |
| Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humans S Malafa, I Medits, JH Aberle, SW Aberle, D Haslwanter, G Tsouchnikas, ... PLoS neglected tropical diseases 14 (2), e0008034, 2020 | 34 | 2020 |
| Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals NA Muena, T García-Salum, C Pardo-Roa, MJ Avendaño, EF Serrano, ... EBioMedicine 78, 2022 | 31 | 2022 |
| Langerhans cell maturation is accompanied by induction of N‐cadherin and the transcriptional regulators of epithelial–mesenchymal transition ZEB1/2 S Konradi, N Yasmin, D Haslwanter, M Weber, B Gesslbauer, M Sixt, ... European journal of immunology 44 (2), 553-560, 2014 | 31 | 2014 |
| Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response JD Herman, C Wang, C Loos, H Yoon, J Rivera, M Eugenia Dieterle, ... Nature communications 12 (1), 6853, 2021 | 29 | 2021 |
| Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein AZ Wec, D Wrapp, AS Herbert, D Maurer, D Haslwanter, M Sakharkar, ... BioRxiv, 2020 | 26 | 2020 |
| Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes G Lasso, S Khan, SA Allen, M Mariano, C Florez, EP Orner, JA Quiroz, ... PLOS Computational Biology 18 (1), e1009778, 2022 | 15 | 2022 |
| Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial R Tschismarov, P Van Damme, C Germain, I De Coster, M Mateo, ... The Lancet 401 (10384), 1267-1276, 2023 | 11 | 2023 |
| Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies D Haslwanter, G Lasso, AZ Wec, ND Furtado, LMS Raphael, ... Cell host & microbe 30 (2), 248-259. e6, 2022 | 11 | 2022 |
| Characterization of the SARS-CoV-2 S Protein: Biophysical NG Herrera, NC Morano, A Celikgil, GI Georgiev, RJ Malonis, JH Lee, ... Biochemical, Structural, and Antigenic Analysis. bioRxiv 2020 (14.150607), 2020 | 11 | 2020 |
| Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibody E Mittler, A Serris, ES Esterman, C Florez, LC Polanco, CM O’Brien, ... Science translational medicine 15 (700), eadg1855, 2023 | 8 | 2023 |
| A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice RJ Malonis, GI Georgiev, D Haslwanter, LA VanBlargan, G Fallon, ... PLoS pathogens 18 (6), e1010573, 2022 | 8 | 2022 |
| Single-dilution COVID-19 antibody test with qualitative and quantitative readouts RH Bortz III, C Florez, E Laudermilch, AS Wirchnianski, G Lasso, ... Msphere 6 (2), 10.1128/msphere. 00224-21, 2021 | 7 | 2021 |
